Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.815 | ||
| Change(%) | ![]() | +0.005 | |
| Volume | 271086 | ||
| 1:35 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Release First Quarter 2009 Earnings on Thursday, May 7, 2009; Conference Call and Webcast to Follow
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential --
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting
Enzon Announces Clinical Data From PEG-SN38 and rhMBL Studies at ASCO -- Company will host reception --

Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon Stockholders Approve Company Proposals at 2009 Annual Meeting
Enzon Pharmaceuticals Extends Tender Offer for a Portion of its Debt
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential --
